DiscoverGI InsightsNavigating Gastrointestinal Impacts of GLP-1 Receptor Agonists
Navigating Gastrointestinal Impacts of GLP-1 Receptor Agonists

Navigating Gastrointestinal Impacts of GLP-1 Receptor Agonists

Update: 2025-06-27
Share

Description

Host: Peter Buch, MD, FACG, AGAF, FACP


Guest: Michael Camilleri, MD




GLP-1 receptor agonists are revolutionizing treatment for diabetes and obesity, but their impact on the gastrointestinal tract demands careful clinical attention. Dr. Peter Buch is joined by Dr. Michael Camilleri, Professor of Medicine at the Mayo Foundation for Medical Education and Research in Rochester, Minnesota, to discuss key findings on gastrointestinal side effects, procedural risks, and the impacts of GLP-1 receptor agonists on the fields of gastroenterology and hepatology.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Navigating Gastrointestinal Impacts of GLP-1 Receptor Agonists

Navigating Gastrointestinal Impacts of GLP-1 Receptor Agonists